These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21753484)

  • 1. Colorectal cancer screening.
    Daly JM; Merchant ML; Levy BT
    Am J Nurs; 2009 Oct; 109(10):60-2. PubMed ID: 21753484
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving the effectiveness of fecal occult blood screening for colorectal cancer.
    Bond JH
    J Natl Cancer Inst; 1999 Oct; 91(19):1602-3. PubMed ID: 10511580
    [No Abstract]   [Full Text] [Related]  

  • 3. In the clinic. Screening for colorectal cancer.
    Weinberg DS; Schoen RE
    Ann Intern Med; 2014 May; 160(9):. PubMed ID: 24798544
    [No Abstract]   [Full Text] [Related]  

  • 4. Decision making in colorectal cancer screening.
    Trowers E; Nguyen W; Cobos E
    J Natl Med Assoc; 1997 Jan; 89(1):9-12. PubMed ID: 9002411
    [No Abstract]   [Full Text] [Related]  

  • 5. Summaries for patients. Use of colorectal cancer screening by doctors in practice.
    Ann Intern Med; 2005 Jan; 142(2):I26. PubMed ID: 15657151
    [No Abstract]   [Full Text] [Related]  

  • 6. Judging the guidelines for colorectal cancer screening.
    Woolf SH; Ganiats TG
    Am Fam Physician; 1997 Jun; 55(8):2595, 2598-600. PubMed ID: 9191445
    [No Abstract]   [Full Text] [Related]  

  • 7. CDC says colorectal cancer screening rates remain low.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Apr; 14(7):10, 12. PubMed ID: 12848150
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for asymptomatic colorectal cancer.
    Mulcahy HE; Farthing MJ; O'Donoghue DP
    BMJ; 1997 Jan; 314(7076):285-91. PubMed ID: 9022495
    [No Abstract]   [Full Text] [Related]  

  • 9. The subjective decision of cessation of colorectal cancer screening.
    Daniel CL; Keyes D; Gilreath K
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):698-699. PubMed ID: 28895544
    [No Abstract]   [Full Text] [Related]  

  • 10. Overcoming the barriers to change: screening for colorectal cancer.
    Woolf SH
    Am Fam Physician; 2000 Mar; 61(6):1621-2, 1628. PubMed ID: 10750871
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical guidelines for the prevention of colorectal cancer].
    Castells A; Marzo M; Bellas B; Amador FJ; Lanas A; Mascort JJ; Ferrándiz J; Alonso P; Piñol V; Fernández M; Bonfill X; Piqué JM
    Gastroenterol Hepatol; 2004 Dec; 27(10):573-634. PubMed ID: 15574281
    [No Abstract]   [Full Text] [Related]  

  • 12. Colorectal cancer. Summary of Canadian screening guidelines.
    Flook N
    Can Fam Physician; 2004 Apr; 50():592-3. PubMed ID: 15116806
    [No Abstract]   [Full Text] [Related]  

  • 13. Colorectal cancer screening: optimal compliance with postal faecal occult blood test.
    King J; Fairbrother G; Thompson C; Morris DL
    Aust N Z J Surg; 1992 Sep; 62(9):714-9. PubMed ID: 1520154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Offering patients colorectal cancer screening.
    Church TR
    J Natl Cancer Inst; 2005 Mar; 97(5):328-9. PubMed ID: 15741562
    [No Abstract]   [Full Text] [Related]  

  • 15. Should organised faecal occult blood test screening be established?
    Autier P
    Ann Oncol; 2002 Jan; 13(1):57-60. PubMed ID: 11863112
    [No Abstract]   [Full Text] [Related]  

  • 16. Is it time to recommend screening for colorectal cancer?
    Lieberman D; Sleisenger MH
    Lancet; 1996 Nov; 348(9040):1463-4. PubMed ID: 8942770
    [No Abstract]   [Full Text] [Related]  

  • 17. Fecal occult blood screening for colorectal cancer.
    Van Dam J; Bond JH; Sivak MV
    Arch Intern Med; 1995 Dec 11-25; 155(22):2389-402. PubMed ID: 7503597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening guidelines for colorectal cancer.
    Bond JH
    Am J Med; 1999 Jan; 106(1A):7S-10S. PubMed ID: 10089107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and surveillance for colorectal cancer.
    Schnoll-Sussman F; Markowitz AJ; Winawer SJ
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):10-21. PubMed ID: 11049028
    [No Abstract]   [Full Text] [Related]  

  • 20. Screen compliance rates in 14-years annual screening program for colorectal cancer with immunochemical fecal occult blood test-- identification of higher priority subjects in health education.
    Wei N; Nakama H; Li T
    Eur J Med Res; 1998 Jul; 3(7):341-4. PubMed ID: 9682030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.